Vincenzo Panichi

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study

Vincenzo Panichi, Giovanni Manca Rizza, Sabrina Paoletti et al. · Nephrology Dialysis Transplantation · 2008 · 224 citations · Full text

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients

Vincenzo Panichi, Umberto Maggiore, Daniele Taccola et al. · Nephrology Dialysis Transplantation · 2004 · 202 citations · Full text

The Agreement between Auscultation and Lung Ultrasound in Hemodialysis Patients: The LUST Study

Claudia Torino, Luna Gargani, Rosa Sicari et al. · Clinical Journal of the American Society of Nephrology · 2016 · 186 citations · Full text

C REACTIVE PROTEIN IN PATIENTS WITH CHRONIC RENAL DISEASES

Vincenzo Panichi, M. Migliori, Stefano De Pietro et al. · Renal Failure · 2001 · 160 citations

Glomerular Disease, Immunology, Plasma Crp +20